Financial TimesBD to acquire Bard in $24 billion medical tech dealReutersNEW YORK Becton Dickinson and Co will acquire C R Bard Inc in a $24 billion cash-and-stock deal that will give shareholders of the target about 15 percent of the combined entity, the two U.S. medical technology companies said on Sunday.